Cargando…

Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab

AIM: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina after injection into the vitreous body. METHODS: Forty-eight rabbits of mixed strain (9–12 months old, weighing ≈ 3.5 kg) were randomized into four groups. Adalimumab was injected at one of two concent...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Anna Cardiakidis, Ghosh, Fredrik, Andréasson, Sten, Ponjavic, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare USA, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238743/
https://www.ncbi.nlm.nih.gov/pubmed/24897597
http://dx.doi.org/10.3109/02713683.2014.898309
_version_ 1782345504440451072
author Myers, Anna Cardiakidis
Ghosh, Fredrik
Andréasson, Sten
Ponjavic, Vesna
author_facet Myers, Anna Cardiakidis
Ghosh, Fredrik
Andréasson, Sten
Ponjavic, Vesna
author_sort Myers, Anna Cardiakidis
collection PubMed
description AIM: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina after injection into the vitreous body. METHODS: Forty-eight rabbits of mixed strain (9–12 months old, weighing ≈ 3.5 kg) were randomized into four groups. Adalimumab was injected at one of two concentrations (1.25 mg or 2.5 mg) into the eyes of two groups, and balanced salt solution into the eyes of the third group. The fourth group acted as controls. Full-field electroretinography (ffERG) was performed before injection and 1 and 6 weeks post-injection. At 6 weeks post-injection the rabbits were euthanized and the sectioned retinas were studied. Retinal histology was studied with hematoxylin–eosin staining. Immunohistochemical analysis was performed on rods, cones, rod bipolar cells, horizontal cells, amacrine cells and Müller cells. RESULTS: No significant difference in ffERG amplitudes or implicit times was observed between the four groups at any time point. Histological and immunohistochemical findings were similar in all groups. CONCLUSIONS: Injection of adalimumab into the vitreous body of healthy rabbits, at doses up to 2.5 mg, does not appear to be toxic to the rabbit retina.
format Online
Article
Text
id pubmed-4238743
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Informa Healthcare USA, Inc.
record_format MEDLINE/PubMed
spelling pubmed-42387432014-11-25 Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab Myers, Anna Cardiakidis Ghosh, Fredrik Andréasson, Sten Ponjavic, Vesna Curr Eye Res Original Article AIM: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina after injection into the vitreous body. METHODS: Forty-eight rabbits of mixed strain (9–12 months old, weighing ≈ 3.5 kg) were randomized into four groups. Adalimumab was injected at one of two concentrations (1.25 mg or 2.5 mg) into the eyes of two groups, and balanced salt solution into the eyes of the third group. The fourth group acted as controls. Full-field electroretinography (ffERG) was performed before injection and 1 and 6 weeks post-injection. At 6 weeks post-injection the rabbits were euthanized and the sectioned retinas were studied. Retinal histology was studied with hematoxylin–eosin staining. Immunohistochemical analysis was performed on rods, cones, rod bipolar cells, horizontal cells, amacrine cells and Müller cells. RESULTS: No significant difference in ffERG amplitudes or implicit times was observed between the four groups at any time point. Histological and immunohistochemical findings were similar in all groups. CONCLUSIONS: Injection of adalimumab into the vitreous body of healthy rabbits, at doses up to 2.5 mg, does not appear to be toxic to the rabbit retina. Informa Healthcare USA, Inc. 2014-11 2014-06-04 /pmc/articles/PMC4238743/ /pubmed/24897597 http://dx.doi.org/10.3109/02713683.2014.898309 Text en © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the CC-BY-NC-ND 3.0 License which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is credited.
spellingShingle Original Article
Myers, Anna Cardiakidis
Ghosh, Fredrik
Andréasson, Sten
Ponjavic, Vesna
Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
title Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
title_full Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
title_fullStr Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
title_full_unstemmed Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
title_short Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
title_sort retinal function and morphology in the rabbit eye after intravitreal injection of the tnf alpha inhibitor adalimumab
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238743/
https://www.ncbi.nlm.nih.gov/pubmed/24897597
http://dx.doi.org/10.3109/02713683.2014.898309
work_keys_str_mv AT myersannacardiakidis retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab
AT ghoshfredrik retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab
AT andreassonsten retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab
AT ponjavicvesna retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab